Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1915 entries
Sorted by: Best Match Show Resources per page
Discrimination between biological interfaces and crystal-packing contacts.

Advances and applications in bioinformatics and chemistry : AABC

Tsuchiya Y, Nakamura H, Kinoshita K.
PMID: 21918609
Adv Appl Bioinform Chem. 2008;1:99-113. doi: 10.2147/aabc.s4255. Epub 2008 Nov 02.

A discrimination method between biologically relevant interfaces and artificial crystal-packing contacts in crystal structures was constructed. The method evaluates protein-protein interfaces in terms of complementarities for hydrophobicity, electrostatic potential and shape on the protein surfaces, and chooses the most...

Cite
Tsuchiya Y, Nakamura H, Kinoshita K. Discrimination between biological interfaces and crystal-packing contacts. Adv Appl Bioinform Chem. 2008;1:99-113doi: 10.2147/aabc.s4255.
Tsuchiya, Y., Nakamura, H., & Kinoshita, K. (2008). Discrimination between biological interfaces and crystal-packing contacts. Advances and applications in bioinformatics and chemistry : AABC, 199-113. https://doi.org/10.2147/aabc.s4255
Tsuchiya, Yuko, et al. "Discrimination between biological interfaces and crystal-packing contacts." Advances and applications in bioinformatics and chemistry : AABC vol. 1 (2008): 99-113. doi: https://doi.org/10.2147/aabc.s4255
Tsuchiya Y, Nakamura H, Kinoshita K. Discrimination between biological interfaces and crystal-packing contacts. Adv Appl Bioinform Chem. 2008;1:99-113. doi: 10.2147/aabc.s4255. Epub 2008 Nov 02. PMID: 21918609; PMCID: PMC3169932.
Copy Download .nbib Format: NLM
Severe, but manageable hypoxia caused by bronchospasm induced by bevacizumab.

Respirology case reports

Taniguchi H, Tsuchida T, Nakamura Y, Motoshima K, Mizoguchi K, Kohno S.
PMID: 25473529
Respirol Case Rep. 2013 Sep;1(1):14-6. doi: 10.1002/rcr2.10. Epub 2013 Aug 29.

Bevacizumab has a lower risk of treatment-related infusion reactions than other humanized monoclonal antibodies, and bronchospasm induced by bevacizumab has not been reported. We administered bevacizumab 15 mg/kg over 90 min infusion to a 34 year-old man with lung...

Cite
Taniguchi H, Tsuchida T, Nakamura Y, et al. Severe, but manageable hypoxia caused by bronchospasm induced by bevacizumab. Respirol Case Rep. 2013;1(1):14-6doi: 10.1002/rcr2.10.
Taniguchi, H., Tsuchida, T., Nakamura, Y., Motoshima, K., Mizoguchi, K., & Kohno, S. (2013). Severe, but manageable hypoxia caused by bronchospasm induced by bevacizumab. Respirology case reports, 1(1), 14-6. https://doi.org/10.1002/rcr2.10
Taniguchi, Hirokazu, et al. "Severe, but manageable hypoxia caused by bronchospasm induced by bevacizumab." Respirology case reports vol. 1,1 (2013): 14-6. doi: https://doi.org/10.1002/rcr2.10
Taniguchi H, Tsuchida T, Nakamura Y, Motoshima K, Mizoguchi K, Kohno S. Severe, but manageable hypoxia caused by bronchospasm induced by bevacizumab. Respirol Case Rep. 2013 Sep;1(1):14-6. doi: 10.1002/rcr2.10. Epub 2013 Aug 29. PMID: 25473529; PMCID: PMC4184640.
Copy Download .nbib Format: NLM
An enlarged intramuscular venous malformation in the femoral region successfully treated with complete resection.

International journal of surgery case reports

Murakami T, Ogata D, Miyano K, Tsuchida T.
PMID: 26945489
Int J Surg Case Rep. 2016;21:83-6. doi: 10.1016/j.ijscr.2016.02.034. Epub 2016 Feb 27.

INTRODUCTION: Intramuscular venous malformations have been previously described as intramuscular hemangiomas, and various therapies have been applied for their treatment. This condition is relatively rare, and therefore, physicians often struggle to determine the appropriate therapy. We presented a case...

Cite
Murakami T, Ogata D, Miyano K, et al. An enlarged intramuscular venous malformation in the femoral region successfully treated with complete resection. Int J Surg Case Rep. 2016;21:83-6doi: 10.1016/j.ijscr.2016.02.034.
Murakami, T., Ogata, D., Miyano, K., & Tsuchida, T. (2016). An enlarged intramuscular venous malformation in the femoral region successfully treated with complete resection. International journal of surgery case reports, 2183-6. https://doi.org/10.1016/j.ijscr.2016.02.034
Murakami, Takuo, et al. "An enlarged intramuscular venous malformation in the femoral region successfully treated with complete resection." International journal of surgery case reports vol. 21 (2016): 83-6. doi: https://doi.org/10.1016/j.ijscr.2016.02.034
Murakami T, Ogata D, Miyano K, Tsuchida T. An enlarged intramuscular venous malformation in the femoral region successfully treated with complete resection. Int J Surg Case Rep. 2016;21:83-6. doi: 10.1016/j.ijscr.2016.02.034. Epub 2016 Feb 27. PMID: 26945489; PMCID: PMC4802186.
Copy Download .nbib Format: NLM
Invasive Liver Abscess Syndrome Caused by Klebsiella pneumoniae.

Internal medicine (Tokyo, Japan)

Setsu T, Tsuchiya A, Yamagiwa S, Terai S.
PMID: 28943583
Intern Med. 2017 Nov 15;56(22):3121-3122. doi: 10.2169/internalmedicine.9014-17. Epub 2017 Sep 25.

No abstract available.

Cite
Setsu T, Tsuchiya A, Yamagiwa S, et al. Invasive Liver Abscess Syndrome Caused by Klebsiella pneumoniae. Intern Med. 2017;56(22):3121-3122doi: 10.2169/internalmedicine.9014-17.
Setsu, T., Tsuchiya, A., Yamagiwa, S., & Terai, S. (2017). Invasive Liver Abscess Syndrome Caused by Klebsiella pneumoniae. Internal medicine (Tokyo, Japan), 56(22), 3121-3122. https://doi.org/10.2169/internalmedicine.9014-17
Setsu, Toru, et al. "Invasive Liver Abscess Syndrome Caused by Klebsiella pneumoniae." Internal medicine (Tokyo, Japan) vol. 56,22 (2017): 3121-3122. doi: https://doi.org/10.2169/internalmedicine.9014-17
Setsu T, Tsuchiya A, Yamagiwa S, Terai S. Invasive Liver Abscess Syndrome Caused by Klebsiella pneumoniae. Intern Med. 2017 Nov 15;56(22):3121-3122. doi: 10.2169/internalmedicine.9014-17. Epub 2017 Sep 25. PMID: 28943583; PMCID: PMC5725875.
Copy Download .nbib Format: NLM
Epiphyseal Sparing and Reconstruction by Frozen Bone Autograft after Malignant Bone Tumor Resection in Children.

Sarcoma

Hamed Kassem Abdelaal A, Yamamoto N, Hayashi K, Takeuchi A, Miwa S, Tsuchiya H.
PMID: 27034614
Sarcoma. 2015;2015:892141. doi: 10.1155/2015/892141. Epub 2015 Dec 21.

Limb salvage surgery has become the standard treatment for malignant primary bone tumors in the extremities. Limb salvage represents a challenge in skeletally immature patients. Several treatment options are available for limb reconstruction after tumor resection in children. We...

Cite
Hamed Kassem Abdelaal A, Yamamoto N, Hayashi K, et al. Epiphyseal Sparing and Reconstruction by Frozen Bone Autograft after Malignant Bone Tumor Resection in Children. Sarcoma. 2015;2015:892141doi: 10.1155/2015/892141.
Hamed Kassem Abdelaal, A., Yamamoto, N., Hayashi, K., Takeuchi, A., Miwa, S., & Tsuchiya, H. (2015). Epiphyseal Sparing and Reconstruction by Frozen Bone Autograft after Malignant Bone Tumor Resection in Children. Sarcoma, 2015892141. https://doi.org/10.1155/2015/892141
Hamed Kassem Abdelaal, Ahmed, et al. "Epiphyseal Sparing and Reconstruction by Frozen Bone Autograft after Malignant Bone Tumor Resection in Children." Sarcoma vol. 2015 (2015): 892141. doi: https://doi.org/10.1155/2015/892141
Hamed Kassem Abdelaal A, Yamamoto N, Hayashi K, Takeuchi A, Miwa S, Tsuchiya H. Epiphyseal Sparing and Reconstruction by Frozen Bone Autograft after Malignant Bone Tumor Resection in Children. Sarcoma. 2015;2015:892141. doi: 10.1155/2015/892141. Epub 2015 Dec 21. PMID: 27034614; PMCID: PMC4807044.
Copy Download .nbib Format: NLM
Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer.

Annals of surgical oncology

Aoyama T, Kawabe T, Fujikawa H, Hayashi T, Yamada T, Tsuchida K, Yukawa N, Oshima T, Rino Y, Masuda M, Ogata T, Cho H, Yoshikawa T.
PMID: 26170193
Ann Surg Oncol. 2015 Dec;22:S1616. doi: 10.1245/s10434-015-4732-8.

No abstract available.

Cite
Aoyama T, Kawabe T, Fujikawa H, et al. Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Ann Surg Oncol. 2015;22:S1616doi: 10.1245/s10434-015-4732-8.
Aoyama, T., Kawabe, T., Fujikawa, H., Hayashi, T., Yamada, T., Tsuchida, K., Yukawa, N., Oshima, T., Rino, Y., Masuda, M., Ogata, T., Cho, H., & Yoshikawa, T. (2015). Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Annals of surgical oncology, 22S1616. https://doi.org/10.1245/s10434-015-4732-8
Aoyama, Toru, et al. "Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer." Annals of surgical oncology vol. 22 (2015): S1616. doi: https://doi.org/10.1245/s10434-015-4732-8
Aoyama T, Kawabe T, Fujikawa H, Hayashi T, Yamada T, Tsuchida K, Yukawa N, Oshima T, Rino Y, Masuda M, Ogata T, Cho H, Yoshikawa T. Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Ann Surg Oncol. 2015 Dec;22:S1616. doi: 10.1245/s10434-015-4732-8. PMID: 26170193.
Copy Download .nbib Format: NLM
Predictive Factors for Non-Sentinel Lymph Node Metastasis in the Case of Positive Sentinel Lymph Node Metastasis in Two or Fewer Nodes in Breast Cancer.

Journal of clinical medicine research

Toshikawa C, Koyama Y, Nagahashi M, Tatsuda K, Moro K, Tsuchida J, Hasegawa M, Niwano T, Manba N, Ikarashi M, Kameyama H, Kobayashi T, Kosugi S, Wakai T.
PMID: 26124908
J Clin Med Res. 2015 Aug;7(8):620-6. doi: 10.14740/jocmr2195w. Epub 2015 Jun 09.

BACKGROUND: In breast cancer, recent clinical trials have shown that sentinel lymph node biopsy (SLNB) alone without axillary lymph node dissection results in excellent prognosis if there is sentinel lymph node (SLN) metastasis in two or fewer nodes. The...

Cite
Toshikawa C, Koyama Y, Nagahashi M, et al. Predictive Factors for Non-Sentinel Lymph Node Metastasis in the Case of Positive Sentinel Lymph Node Metastasis in Two or Fewer Nodes in Breast Cancer. J Clin Med Res. 2015;7(8):620-6doi: 10.14740/jocmr2195w.
Toshikawa, C., Koyama, Y., Nagahashi, M., Tatsuda, K., Moro, K., Tsuchida, J., Hasegawa, M., Niwano, T., Manba, N., Ikarashi, M., Kameyama, H., Kobayashi, T., Kosugi, S., & Wakai, T. (2015). Predictive Factors for Non-Sentinel Lymph Node Metastasis in the Case of Positive Sentinel Lymph Node Metastasis in Two or Fewer Nodes in Breast Cancer. Journal of clinical medicine research, 7(8), 620-6. https://doi.org/10.14740/jocmr2195w
Toshikawa, Chie, et al. "Predictive Factors for Non-Sentinel Lymph Node Metastasis in the Case of Positive Sentinel Lymph Node Metastasis in Two or Fewer Nodes in Breast Cancer." Journal of clinical medicine research vol. 7,8 (2015): 620-6. doi: https://doi.org/10.14740/jocmr2195w
Toshikawa C, Koyama Y, Nagahashi M, Tatsuda K, Moro K, Tsuchida J, Hasegawa M, Niwano T, Manba N, Ikarashi M, Kameyama H, Kobayashi T, Kosugi S, Wakai T. Predictive Factors for Non-Sentinel Lymph Node Metastasis in the Case of Positive Sentinel Lymph Node Metastasis in Two or Fewer Nodes in Breast Cancer. J Clin Med Res. 2015 Aug;7(8):620-6. doi: 10.14740/jocmr2195w. Epub 2015 Jun 09. PMID: 26124908; PMCID: PMC4471749.
Copy Download .nbib Format: NLM
Erratum to: Evidence-based clinical practice guidelines for polycystic kidney disease 2014.

Clinical and experimental nephrology

Horie S, Mochizuki T, Muto S, Hanaoka K, Fukushima Y, Narita I, Nutahara K, Tsuchiya K, Tsuruya K, Kamura K, Nishio S, Suwabe T, Ubara Y, Ishimura E, Nakanishi K, Furukawa K, Kimura K, Matsuo S.
PMID: 27358079
Clin Exp Nephrol. 2016 Aug;20(4):510. doi: 10.1007/s10157-016-1285-5.

No abstract available.

Cite
Horie S, Mochizuki T, Muto S, et al. Erratum to: Evidence-based clinical practice guidelines for polycystic kidney disease 2014. Clin Exp Nephrol. 2016;20(4):510doi: 10.1007/s10157-016-1285-5.
Horie, S., Mochizuki, T., Muto, S., Hanaoka, K., Fukushima, Y., Narita, I., Nutahara, K., Tsuchiya, K., Tsuruya, K., Kamura, K., Nishio, S., Suwabe, T., Ubara, Y., Ishimura, E., Nakanishi, K., Furukawa, K., Kimura, K., & Matsuo, S. (2016). Erratum to: Evidence-based clinical practice guidelines for polycystic kidney disease 2014. Clinical and experimental nephrology, 20(4), 510. https://doi.org/10.1007/s10157-016-1285-5
Horie, Shigeo, et al. "Erratum to: Evidence-based clinical practice guidelines for polycystic kidney disease 2014." Clinical and experimental nephrology vol. 20,4 (2016): 510. doi: https://doi.org/10.1007/s10157-016-1285-5
Horie S, Mochizuki T, Muto S, Hanaoka K, Fukushima Y, Narita I, Nutahara K, Tsuchiya K, Tsuruya K, Kamura K, Nishio S, Suwabe T, Ubara Y, Ishimura E, Nakanishi K, Furukawa K, Kimura K, Matsuo S. Erratum to: Evidence-based clinical practice guidelines for polycystic kidney disease 2014. Clin Exp Nephrol. 2016 Aug;20(4):510. doi: 10.1007/s10157-016-1285-5. PMID: 27358079; PMCID: PMC6828247.
Copy Download .nbib Format: NLM
Advanced methods of microscope control using μManager software.

Journal of biological methods

Edelstein AD, Tsuchida MA, Amodaj N, Pinkard H, Vale RD, Stuurman N.
PMID: 25606571
J Biol Methods. 2014;1(2). doi: 10.14440/jbm.2014.36.

μManager is an open-source, cross-platform desktop application, to control a wide variety of motorized microscopes, scientific cameras, stages, illuminators, and other microscope accessories. Since its inception in 2005, μManager has grown to support a wide range of microscopy hardware...

Cite
Edelstein AD, Tsuchida MA, Amodaj N, et al. Advanced methods of microscope control using μManager software. J Biol Methods. 2014;1(2)doi: 10.14440/jbm.2014.36.
Edelstein, A. D., Tsuchida, M. A., Amodaj, N., Pinkard, H., Vale, R. D., & Stuurman, N. (2014). Advanced methods of microscope control using μManager software. Journal of biological methods, 1(2), . https://doi.org/10.14440/jbm.2014.36
Edelstein, Arthur D, et al. "Advanced methods of microscope control using μManager software." Journal of biological methods vol. 1,2 (2014). doi: https://doi.org/10.14440/jbm.2014.36
Edelstein AD, Tsuchida MA, Amodaj N, Pinkard H, Vale RD, Stuurman N. Advanced methods of microscope control using μManager software. J Biol Methods. 2014;1(2). doi: 10.14440/jbm.2014.36. PMID: 25606571; PMCID: PMC4297649.
Copy Download .nbib Format: NLM
Frequency of nonsteroidal anti-inflammatory drug-associated ulcers.

Clinical journal of gastroenterology

Hiraishi H, Oki R, Tsuchida K, Yoshitake N, Tominaga K, Kusano K, Hashimoto T, Maeda M, Sasai T, Shimada T.
PMID: 26182316
Clin J Gastroenterol. 2012 Jun;5(3):171-6. doi: 10.1007/s12328-012-0300-y. Epub 2012 Apr 24.

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for treatment of orthopedic diseases, inflammatory diseases, etc., and low-dose aspirin is a common antiplatelet therapy given mainly for secondary prevention of atherothrombosis (e.g., myocardial infarction and cerebral infarction). As to the...

Cite
Hiraishi H, Oki R, Tsuchida K, et al. Frequency of nonsteroidal anti-inflammatory drug-associated ulcers. Clin J Gastroenterol. 2012;5(3):171-6doi: 10.1007/s12328-012-0300-y.
Hiraishi, H., Oki, R., Tsuchida, K., Yoshitake, N., Tominaga, K., Kusano, K., Hashimoto, T., Maeda, M., Sasai, T., & Shimada, T. (2012). Frequency of nonsteroidal anti-inflammatory drug-associated ulcers. Clinical journal of gastroenterology, 5(3), 171-6. https://doi.org/10.1007/s12328-012-0300-y
Hiraishi, Hideyuki, et al. "Frequency of nonsteroidal anti-inflammatory drug-associated ulcers." Clinical journal of gastroenterology vol. 5,3 (2012): 171-6. doi: https://doi.org/10.1007/s12328-012-0300-y
Hiraishi H, Oki R, Tsuchida K, Yoshitake N, Tominaga K, Kusano K, Hashimoto T, Maeda M, Sasai T, Shimada T. Frequency of nonsteroidal anti-inflammatory drug-associated ulcers. Clin J Gastroenterol. 2012 Jun;5(3):171-6. doi: 10.1007/s12328-012-0300-y. Epub 2012 Apr 24. PMID: 26182316.
Copy Download .nbib Format: NLM
Erratum to: Short-Segment Coil Embolization Using a Double-Balloon Technique in an Experimental Vascular Model.

Cardiovascular and interventional radiology

Yunaiyama D, Saguchi T, Moriya T, Shirota N, Otaka J, Tokuuye K, Nagakawa Y, Tsuchida A, Saito K.
PMID: 28547125
Cardiovasc Intervent Radiol. 2017 Aug;40(8):1299. doi: 10.1007/s00270-017-1647-8.

No abstract available.

Cite
Yunaiyama D, Saguchi T, Moriya T, et al. Erratum to: Short-Segment Coil Embolization Using a Double-Balloon Technique in an Experimental Vascular Model. Cardiovasc Intervent Radiol. 2017;40(8):1299doi: 10.1007/s00270-017-1647-8.
Yunaiyama, D., Saguchi, T., Moriya, T., Shirota, N., Otaka, J., Tokuuye, K., Nagakawa, Y., Tsuchida, A., & Saito, K. (2017). Erratum to: Short-Segment Coil Embolization Using a Double-Balloon Technique in an Experimental Vascular Model. Cardiovascular and interventional radiology, 40(8), 1299. https://doi.org/10.1007/s00270-017-1647-8
Yunaiyama, Daisuke, et al. "Erratum to: Short-Segment Coil Embolization Using a Double-Balloon Technique in an Experimental Vascular Model." Cardiovascular and interventional radiology vol. 40,8 (2017): 1299. doi: https://doi.org/10.1007/s00270-017-1647-8
Yunaiyama D, Saguchi T, Moriya T, Shirota N, Otaka J, Tokuuye K, Nagakawa Y, Tsuchida A, Saito K. Erratum to: Short-Segment Coil Embolization Using a Double-Balloon Technique in an Experimental Vascular Model. Cardiovasc Intervent Radiol. 2017 Aug;40(8):1299. doi: 10.1007/s00270-017-1647-8. PMID: 28547125; PMCID: PMC5489587.
Copy Download .nbib Format: NLM
Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model.

Oncotarget

Igarashi K, Kawaguchi K, Kiyuna T, Murakami T, Miwa S, Nelson SD, Dry SM, Li Y, Singh AS, Kimura H, Hayashi K, Yamamoto N, Tsuchiya H, Eilber FC, Hoffman RM.
PMID: 29100276
Oncotarget. 2017 Mar 24;8(44):75874-75880. doi: 10.18632/oncotarget.16548. eCollection 2017 Sep 29.

Adult pleomorphic rhabdomyosarcoma (RMS) is a rare and recalcitrant, highly-malignant mesenchymal tumor in need of improved therapeutic strategies. Our laboratory pioneered the patient-derived orthotopic xenograft (PDOX) nude mouse model with the technique of surgical orthotopic implantation (SOI). We previously...

Cite
Igarashi K, Kawaguchi K, Kiyuna T, et al. Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model. Oncotarget. 2017;8(44):75874-75880doi: 10.18632/oncotarget.16548.
Igarashi, K., Kawaguchi, K., Kiyuna, T., Murakami, T., Miwa, S., Nelson, S. D., Dry, S. M., Li, Y., Singh, A. S., Kimura, H., Hayashi, K., Yamamoto, N., Tsuchiya, H., Eilber, F. C., & Hoffman, R. M. (2017). Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model. Oncotarget, 8(44), 75874-75880. https://doi.org/10.18632/oncotarget.16548
Igarashi, Kentaro, et al. "Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model." Oncotarget vol. 8,44 (2017): 75874-75880. doi: https://doi.org/10.18632/oncotarget.16548
Igarashi K, Kawaguchi K, Kiyuna T, Murakami T, Miwa S, Nelson SD, Dry SM, Li Y, Singh AS, Kimura H, Hayashi K, Yamamoto N, Tsuchiya H, Eilber FC, Hoffman RM. Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model. Oncotarget. 2017 Mar 24;8(44):75874-75880. doi: 10.18632/oncotarget.16548. eCollection 2017 Sep 29. PMID: 29100276; PMCID: PMC5652670.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1915 entries